Mesenchymal Stem Cells and Their Exosomes Mitigate Osteoarthritis by Restoring the Balance Between Proinflammatory Teffs and Tregs

Overview

Journal Front Aging

Specialty Geriatrics

Date 2024 Dec 4

PMID 39629263

Authors

Tianhao Liu

Chunxiao Ran

Dewei Zhao

Fan Yang

Qiang Guo

Jiahui Yang

Xiuzhi Zhang

Affiliations

Soon will be listed here.

Abstract

Osteoarthritis (OA) is a degenerative joint disease caused by chronic inflammation that damages articular cartilage. In addition to the wear and tear of joints, aberrant remodelling driven by a significant presence of inflammatory mediators within the joint is one of the key mechanisms in the pathogenesis of OA. Among these factors, hyperactivation of Teffs subsets plays a crucial role in promoting this pathological process. The immune imbalance between proinflammatory CD4 effector T cells (proinflammatory Teffs) and Tregs could be a crucial factor in the pathogenesis of OA. Therefore, correcting the imbalance of Tregs/proinflammatory Teffs may slow or inhibit the occurrence and development of OA, which could be a potential target for the treatment of OA. Mesenchymal stem cells (MSCs) possess anti-inflammatory and immunomodulatory properties, regulating both adaptive and innate immunity through mechanisms involving soluble factors such as IDO, PGE2, and TGF-β, as well as cell-to-cell contact and exosomes. Correcting the imbalance between Tregs and proinflammatory Teffs may be one of the mechanisms of MSCs in the treatment of OA. Therefore, this review aims to summarize the relationship between OA and the immune imbalance between Tregs and proinflammatory Teffs, the immunoregulatory role of Tregs in OA, and the role of MSCs and their exosomes in correcting the imbalance between Tregs and proinflammatory Teffs.

References

Ponchel F, Burska A, Hensor E, Raja R, Campbell M, Emery P . Changes in peripheral blood immune cell composition in osteoarthritis. Osteoarthritis Cartilage. 2015; 23(11):1870-8. PMC: 4638189. DOI: 10.1016/j.joca.2015.06.018. View

Krasnokutsky S, Belitskaya-Levy I, Bencardino J, Samuels J, Attur M, Regatte R . Quantitative magnetic resonance imaging evidence of synovial proliferation is associated with radiographic severity of knee osteoarthritis. Arthritis Rheum. 2011; 63(10):2983-91. PMC: 3183134. DOI: 10.1002/art.30471. View

Bernardo M, Fibbe W . Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell. 2013; 13(4):392-402. DOI: 10.1016/j.stem.2013.09.006. View

Zhang Z, Guo J, Jia R . Treg plasticity and human diseases. Inflamm Res. 2023; 72(12):2181-2197. DOI: 10.1007/s00011-023-01808-x. View

Guo L, Lai P, Geng S, Chen X, Wang Y, Huang T . [Regulatory Effect of Exosomes Derived from Human Umbiilcal Cord Mesenchymal Stem Cells on Treg and TH17 Cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019; 27(1):221-226. DOI: 10.7534/j.issn.1009-2137.2019.01.036. View

Apinun J, Sengprasert P, Yuktanandana P, Ngarmukos S, Tanavalee A, Reantragoon R . Immune Mediators in Osteoarthritis: Infrapatellar Fat Pad-Infiltrating CD8+ T Cells Are Increased in Osteoarthritic Patients with Higher Clinical Radiographic Grading. Int J Rheumatol. 2017; 2016:9525724. PMC: 5192329. DOI: 10.1155/2016/9525724. View

Kobie J, Shah P, Yang L, Rebhahn J, Fowell D, Mosmann T . T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine. J Immunol. 2006; 177(10):6780-6. DOI: 10.4049/jimmunol.177.10.6780. View

Lippens C, Duraes F, Dubrot J, Brighouse D, Lacroix M, Irla M . IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity. J Autoimmun. 2016; 75():39-49. PMC: 5127883. DOI: 10.1016/j.jaut.2016.07.004. View

Mohan D, Sherman H, Mitra A, Lawlor R, Shanthalingam S, Ullom J . LKB1 isoform expression modulates T cell plasticity downstream of PKCθ and IL-6. Mol Immunol. 2023; 157:129-141. DOI: 10.1016/j.molimm.2023.03.020. View

10.

Nguyen T, Duong C, Nguyen X, Than U . Mesenchymal Stem Cell-Derived Extracellular Vesicles for Osteoarthritis Treatment: Extracellular Matrix Protection, Chondrocyte and Osteocyte Physiology, Pain and Inflammation Management. Cells. 2021; 10(11). PMC: 8616200. DOI: 10.3390/cells10112887. View

11.

Li C, Sheng A, Jia X, Zeng Z, Zhang X, Zhao W . Th17/Treg dysregulation in allergic asthmatic children is associated with elevated notch expression. J Asthma. 2017; 55(1):1-7. DOI: 10.1080/02770903.2016.1266494. View

12.

Pandiyan P, Zheng L, Lenardo M . The molecular mechanisms of regulatory T cell immunosuppression. Front Immunol. 2012; 2:60. PMC: 3342245. DOI: 10.3389/fimmu.2011.00060. View

13.

Vignali D, Collison L, Workman C . How regulatory T cells work. Nat Rev Immunol. 2008; 8(7):523-32. PMC: 2665249. DOI: 10.1038/nri2343. View

14.

Sakkas L, Scanzello C, Johanson N, Burkholder J, Mitra A, Salgame P . T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clin Diagn Lab Immunol. 1998; 5(4):430-7. PMC: 95595. DOI: 10.1128/CDLI.5.4.430-437.1998. View

15.

Li Y, Luo W, Zhu S, Lei G . T Cells in Osteoarthritis: Alterations and Beyond. Front Immunol. 2017; 8:356. PMC: 5371609. DOI: 10.3389/fimmu.2017.00356. View

16.

Glyn-Jones S, Palmer A, Agricola R, Price A, Vincent T, Weinans H . Osteoarthritis. Lancet. 2015; 386(9991):376-87. DOI: 10.1016/S0140-6736(14)60802-3. View

17.

Peng Y, Jiang H, Zuo H . Factors affecting osteogenesis and chondrogenic differentiation of mesenchymal stem cells in osteoarthritis. World J Stem Cells. 2023; 15(6):548-560. PMC: 10324504. DOI: 10.4252/wjsc.v15.i6.548. View

18.

Wang Z, Yan K, Ge G, Zhang D, Bai J, Guo X . Exosomes derived from miR-155-5p-overexpressing synovial mesenchymal stem cells prevent osteoarthritis via enhancing proliferation and migration, attenuating apoptosis, and modulating extracellular matrix secretion in chondrocytes. Cell Biol Toxicol. 2020; 37(1):85-96. DOI: 10.1007/s10565-020-09559-9. View

19.

Zhu L, Hua F, Ding W, Ding K, Zhang Y, Xu C . The correlation between the Th17/Treg cell balance and bone health. Immun Ageing. 2020; 17:30. PMC: 7557094. DOI: 10.1186/s12979-020-00202-z. View

20.

So L, Obata-Ninomiya K, Hu A, Muir V, Takamori A, Song J . Regulatory T cells suppress CD4+ effector T cell activation by controlling protein synthesis. J Exp Med. 2023; 220(3). PMC: 9827529. DOI: 10.1084/jem.20221676. View